Australia markets closed

VRTX Jan 2023 185.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
129.000.00 (0.00%)
As of 10:29AM EST. Market open.
Full screen
Previous close129.00
Open129.00
Bid0.00
Ask0.00
Strike185.00
Expiry date2023-01-20
Day's range129.00 - 129.00
Contract rangeN/A
Volume1
Open interestN/A
  • Motley Fool

    Is This Biotech Stock a Buy Following a Landmark Approval?

    Provention Bio (NASDAQ: PRVB) is a small-cap biotech whose shares have doubled in the past three months. The company can thank the expected and eventual approval of Tzield for that performance. In mid-November, Tzield became the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for the delay of the onset of type 1 diabetes (T1D) in at-risk patients.

  • Simply Wall St.

    Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 124%

    When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

  • Motley Fool

    3 Stocks to Buy Hand Over Fist in December

    Here's why they think that AbbVie (NYSE: ABBV), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX) are stocks to buy hand over fist in December. Prosper Junior Bakiny (AbbVie): The end of the year is always a great time to review your investment portfolio. The drugmaker is set to lose U.S. patent protection for its biggest cash cow -- autoimmune-disease medicine Humira -- next year.